Medicare Coverage for Blood Tests to Screen Early Alzheimer's and Dementia.
This Act amends the Social Security Act to mandate Medicare coverage for blood-based screening tests designed for the early detection of Alzheimer's disease and related dementias. This change ensures that citizens covered by Medicare will have access to advanced testing for pre-symptomatic or early-stage detection, facilitating timely intervention. The new coverage provisions are scheduled to take effect starting January 1, 2028.
Key points
Medicare Expansion: Medicare coverage will be extended to include early detection screening tests for Alzheimer's disease and related dementias.
Early Detection Focus: The tests covered are specifically for detecting the pre-symptomatic and early stages of the disease, crucial for potential treatment effectiveness.
Covered Tests: Coverage includes genomic sequencing blood tests and other FDA-approved equivalent tests, such as protein analysis and medical imaging based on biospecimens.
Effective Date: These new benefits will become available to Medicare beneficiaries starting on January 1, 2028.
Status:
Introduced
Civic Will
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.